Literature DB >> 17151928

Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in Italian BRCA1/2 carriers.

C Pepe1, L Guidugli, E Sensi, P Aretini, E D'Andrea, M Montagna, S Manoukian, L Ottini, P Radice, A Viel, G Bevilacqua, M A Caligo.   

Abstract

BRCA1 and 2 are major cancer susceptibility genes but their penetrance is highly variable. The folate metabolism plays an important role in DNA methylation and its alterated metabolism is associated with cancer risk. The role of allele variants 677T and 1298C (MTHFR gene) and 2756G (MS gene) has been investigated as potentially modifying factors of BRCA gene penetrance, evaluated as age at first diagnosis of cancer, in 484 BRCA1/BRCA2 carriers and in 108 sporadic breast cancer cases as a control group. The genotype analysis has been performed by means of PCR/RFLP's. The analysis of association between a particular genotype and disease risk was performed using Cox Regression with time to breast or ovarian cancer onset as the end-point. The presence of 677T allele confers an increased risk of breast cancer in BRCA1 carriers (P = 0.007) and the presence of 1298C allele confers an increased risk of breast cancer in sporadic cases (P = 0.015).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17151928     DOI: 10.1007/s10549-006-9349-y

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  13 in total

Review 1.  Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Authors:  David J Hughes
Journal:  Fam Cancer       Date:  2008-02-19       Impact factor: 2.375

2.  Folate intake and MTHFR polymorphism C677T is not associated with ovarian cancer risk: evidence from the meta-analysis.

Authors:  Chenglin Li; Peizhan Chen; Pingting Hu; Mian Li; Xiaoguang Li; He Guo; Jingquan Li; Ruiai Chu; Wei Zhang; Hui Wang
Journal:  Mol Biol Rep       Date:  2013-10-17       Impact factor: 2.316

3.  Epistatic interactions between loci of one-carbon metabolism modulate susceptibility to breast cancer.

Authors:  Shaik Mohammad Naushad; Addepalli Pavani; Raghunadha Rao Digumarti; Suryanarayana Raju Gottumukkala; Vijay Kumar Kutala
Journal:  Mol Biol Rep       Date:  2010-12-14       Impact factor: 2.316

4.  Gene-Gene Interaction Study Between Genetic Polymorphisms of Folate Metabolism and MTR SNPs on Prognostic Features Impact for Breast Cancer.

Authors:  Moataza Hassan Omran; Basma El-Sayed Fotouh; Wafaa Ghoneim Shosha; Abeer Ismail; Shimaa Shawki Ramadan
Journal:  Rep Biochem Mol Biol       Date:  2022-04

5.  The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals.

Authors:  Chengbin Ma; Yan Liu; Wenying Zhang; Ping Liu
Journal:  Mol Biol Rep       Date:  2013-01-18       Impact factor: 2.316

Review 6.  A literature review of MTHFR (C677T and A1298C polymorphisms) and cancer risk.

Authors:  Muzeyyen Izmirli
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

7.  Alcohol consumption and genetic variation in methylenetetrahydrofolate reductase and 5-methyltetrahydrofolate-homocysteine methyltransferase in relation to breast cancer risk.

Authors:  Mary E Platek; Peter G Shields; Catalin Marian; Susan E McCann; Matthew R Bonner; Jing Nie; Christine B Ambrosone; Amy E Millen; Heather M Ochs-Balcom; Sylvia K Quick; Maurizio Trevisan; Marcia Russell; Thomas H Nochajski; Stephen B Edge; Jo L Freudenheim
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08-25       Impact factor: 4.254

8.  A system for detecting high impact-low frequency mutations in primary tumors and metastases.

Authors:  M Anjanappa; Y Hao; E R Simpson; P Bhat-Nakshatri; J B Nelson; S A Tersey; R G Mirmira; A A Cohen-Gadol; M R Saadatzadeh; L Li; F Fang; K P Nephew; K D Miller; Y Liu; H Nakshatri
Journal:  Oncogene       Date:  2017-09-11       Impact factor: 9.867

9.  Strong Correlation of MTHFR Gene Polymorphisms with Breast Cancer and its Prognostic Clinical Factors among Egyptian Females.

Authors:  Moataza H Omran; Basma E Fotouh; Wafaa G Shousha; Abeer Ismail; Noha E Ibrahim; Shimaa S Ramadan
Journal:  Asian Pac J Cancer Prev       Date:  2021-02-01

10.  Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study.

Authors:  A Jakubowska; D Rozkrut; A Antoniou; U Hamann; R J Scott; L McGuffog; S Healy; O M Sinilnikova; G Rennert; F Lejbkowicz; A Flugelman; I L Andrulis; G Glendon; H Ozcelik; M Thomassen; M Paligo; P Aretini; J Kantala; B Aroer; A von Wachenfeldt; A Liljegren; N Loman; K Herbst; U Kristoffersson; R Rosenquist; P Karlsson; M Stenmark-Askmalm; B Melin; K L Nathanson; S M Domchek; T Byrski; T Huzarski; J Gronwald; J Menkiszak; C Cybulski; P Serrano; A Osorio; T R Cajal; M Tsitlaidou; J Benítez; M Gilbert; M Rookus; C M Aalfs; I Kluijt; J L Boessenkool-Pape; H E J Meijers-Heijboer; J C Oosterwijk; C J van Asperen; M J Blok; M R Nelen; A M W van den Ouweland; C Seynaeve; R B van der Luijt; P Devilee; D F Easton; S Peock; D Frost; R Platte; S D Ellis; E Fineberg; D G Evans; F Lalloo; R Eeles; C Jacobs; J Adlard; R Davidson; D Eccles; T Cole; J Cook; A Godwin; B Bove; D Stoppa-Lyonnet; V Caux-Moncoutier; M Belotti; C Tirapo; S Mazoyer; L Barjhoux; N Boutry-Kryza; P Pujol; I Coupier; J-P Peyrat; P Vennin; D Muller; J-P Fricker; L Venat-Bouvet; O Th Johannsson; C Isaacs; R Schmutzler; B Wappenschmidt; A Meindl; N Arnold; R Varon-Mateeva; D Niederacher; C Sutter; H Deissler; S Preisler-Adams; J Simard; P Soucy; F Durocher; G Chenevix-Trench; J Beesley; X Chen; T Rebbeck; F Couch; X Wang; N Lindor; Z Fredericksen; V S Pankratz; P Peterlongo; B Bonanni; S Fortuzzi; B Peissel; C Szabo; P L Mai; J T Loud; J Lubinski
Journal:  Br J Cancer       Date:  2012-05-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.